Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Shenzhen Mindray Bio-Medical (+21.1%) reported second quarter results with revenue rising 10% year-on-year and a return to double-digit growth for the first time since channel destocking began in late 2024. First-half reported profit...
— Sharukh Malik, Edmund Harriss
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
No other institutional pitches found for this ticker yet.
More institutional theses from Guinness China
Shanghai Putailai New Energy is a vertically integrated provider of lithium-ion battery components, producing coated separators, base films, synthetic anodes, and specialized manufacturing equipment. The manager remains...
Xiamen Faratronic manufactures film capacitors used in industrial power electronics, renewable energy infrastructure, electric vehicles, and data centers. The investment manager...
Shandong Sinocera represents 3.9% of the fund's portfolio and produces specialized advanced ceramic materials, including MLCC ceramic powders, dental ceramics, and high-performance substrate materials. The manager maintains...